CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 63 filers reported holding CATABASIS PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $130,000 | -9.7% | 61,444 | +23.4% | 0.00% | – |
| Q1 2021 | $144,000 | +14.3% | 49,798 | -15.3% | 0.00% | – |
| Q4 2020 | $126,000 | -92.2% | 58,827 | -77.5% | 0.00% | -100.0% |
| Q3 2020 | $1,617,000 | -1.5% | 261,221 | +2.4% | 0.00% | 0.0% |
| Q2 2020 | $1,641,000 | +60.7% | 255,167 | +3.7% | 0.00% | 0.0% |
| Q1 2020 | $1,021,000 | -26.9% | 245,974 | +4.1% | 0.00% | 0.0% |
| Q4 2019 | $1,397,000 | +14.9% | 236,374 | +4.9% | 0.00% | – |
| Q3 2019 | $1,216,000 | -31.1% | 225,261 | +3.0% | 0.00% | -100.0% |
| Q2 2019 | $1,765,000 | +50.3% | 218,651 | +47.5% | 0.00% | – |
| Q1 2019 | $1,174,000 | – | 148,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eversept Partners, LP | 522,042 | $1,117,170 | 0.13% |
| XTX MARKETS LLC | 26,041 | $56,000 | 0.12% |
| Samsara BioCapital, LLC | 300,000 | $642,000 | 0.06% |
| Ikarian Capital, LLC | 650,000 | $1,392,000 | 0.06% |
| Opaleye Management Inc. | 187,750 | $402,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 108,026 | $231,000 | 0.04% |
| Anson Funds Management LP | 97,601 | $209,000 | 0.04% |
| Virtu Financial LLC | 83,221 | $178,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 47,084 | $101,000 | 0.02% |
| WEXFORD CAPITAL LP | 19,512 | $42,000 | 0.01% |